Hydrafacial Investor Day Presentation Deck slide image

Hydrafacial Investor Day Presentation Deck

Bridge to 25-30% adj. EBITDA margin: reaping the benefits of our investments 121 2021 Adj. EBITDA Margin Up to 5% Gains in COGS Value engineering Up to 10% Gains in G&A Fixed cost leverage as infrastructure build completes Gains in S&M Efficiencies as brand awareness increases and mix shifts to consumables 25-30% Expected Margin Note: Adjusted EBITDA is a non-GAAP measure; please refer to the appendix for a discussion of the definition of this measure and important information regarding the assumptions underlying the outlook. 2025E Adj. EBITDA Margin We anticipate continual adjusted EBITDA margin expansion each year, starting with an estimated 18 - 20% margin in 2023 BEAUTYHEALTH™
View entire presentation